Skip to main content

Table 11 Comparasion of the Pfizer and AstraZeneca vaccination centers during the vaccine preparation process*

From: Vaccination process evaluation at COVID-19 vaccination centers in Lebanon: a national study

Questions

PZ

N = 20 (%)

AZ

N = 13 (%)

Total vaccines

N = 33 (%)

P-value

1. Proper hygiene is followed during the preparation process

 No

1 (5.0)

1 (7.7)

2 (6.1)

0.84

 Yes

15 (75.0)

8 (61.5)

23 (69.7)

 Not observed

4 (20.0)

4 (30.8)

8 (24.2)

2. Double check vial label and expiration date prior to drawing up

 No

1 (5.0)

0 (0.0)

10 (30.3)

0.808

 Yes

15 (75.0)

9 (69.2)

15 (45.5)

 Not observed

4 (20.0)

4 (30.8)

8 (24.2)

3. Qualified and well-trained individuals are responsible for the vaccine preparation

 No

1 (5.0)

1 (7.7)

2 (6.1)

1.0

 Yes

19 (95.0)

12 (92.3)

31 (93.9)

4. Vaccines are being prepared in a designated area, away from any potentially contaminated items

 No

1 (5.0)

1 (7.7)

2 (6.1)

1.0

 Yes

19 (95.0)

12 (92.3)

31 (93.9)

5. Time of preparation is documented

 No

5 (25.0)

8 (61.5)

13 (39.4)

0.036*

 Yes

15 (75.0)

5 (38.5)

20 (60.6)

6. Name of the vaccine and lot number are documented

 No

2 (10.0)

1 (7.7)

3 (9.1)

1.0

 Yes

18 (90.0)

12 (92.3)

30 (90.9)

7. Once drawn up, vaccines are kept at room temperature (+ 2 °C to + 25 °C) up to 6 h

 No

1 (5.0)

0 (0.0)

1 (3.0)

1.0

 Yes

19 (95.0)

13 (100.0)

32 (97.0)

  1. *Statistical tests used included Pearson’s Chi-squared test or Fisher’s exact test